Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options



Rating:

Share or cite this content

Citations should be made in the following way:
R. Vos, B. Vanaudenaerde, S. De Vleeschauwer, A. Willems-Widyastuti, A. Schoonis, D. Van Raemdonck, L. Dupont, G. Verleden (Leuven, Belgium). Lymphocytic bronchiolitis after lung transplantation: a role for azithromycin?. Eur Respir J 2009; 34: Suppl. 53, 180

Member's Comments

No comment yet.

Related content which might interest you: Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure? Source: Eur Respir J 2011; 37: 10-12 Year: 2011 Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation? Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible? Year: 2006 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008 Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Source: Eur Respir J 2008; 31: 1037-1045 Year: 2008 Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004 Exploring the BAL profile in acute rejection and lymphocytic bronchiolitis after lung transplantation Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options Year: 2009 Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004 Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005 Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans Source: International Congress 2016 – Orphan diseases I Year: 2016 Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 Fourth lung transplantation for bronchiolitis obliterans in a patient with cystic fibrosis Source: Annual Congress 2007 - Complications and success in lung transplantation Year: 2007 Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004 The role of azithromycin after lung transplantation Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study Source: Eur Respir J 2005; 25: 490-493 Year: 2005 Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9 Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006 LATE-BREAKING ABSTRACT: Nitrogen multiple breath washout for diagnosis of biopsy-proven bronchiolitis obliterans in patients after allogeneic stem cell transplantation Source: International Congress 2016 – Dyspnoea and respiratory muscle/mechanics anomalies in disease Year: 2016 Introduction: new therapeutic approaches to bronchiolitis obliterans Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005 The Leuven experience with a dichotomy in Bronchiolitis Obliterans Syndrome (BOS) after lung transplantation revealed by azithromycin Source: Eur Respir Rev 2008; 17: 93-95 Year: 2008